OBJECTIVE: Recurrence of chronic subdural hematoma is not rare. Among patie
nts who experience recurrence, severe background disease may adversely infl
uence the prognosis of chronic subdural hematoma. We treated patients with
these refractory hematomas with an Ommaya cerebrospinal fluid (CSF) reservo
ir and analyzed the effectiveness of the treatment.
METHODS: Sixteen patients with refractory chronic subdural hematoma were st
udied. These patients had severe diseases that adversely influenced the cli
nical courser of chronic subdural hematoma, including cerebral infarction,
liver cirrhosis, thrombocytopenia, severe Parkinsonism, severe heart diseas
e, psychiatric disease, and spinocerebellar degeneration. All patients were
treated initially in the standard fashion: evacuation of the hematoma foll
owed by irrigation and drainage of the hematoma cavity. In each patient, an
Ommaya CSF reservoir was implanted after the hematoma recurred. Whenever t
he volume of the hematoma either decreased very slowly or increased, the re
servoir was punctured.
RESULTS: The hematoma size decreased to less than 3 mm a median of 60 days
after introduction of the reservoir. Postoperatively, 13 patients returned
to their condition before the onset of hematoma. One patient died of myocar
dial infarction, and two patients with Parkinson's disease could not mainta
in their previous functional level; both remained in a partially dependent
state. Complications consisted of minor bleeding in two patients and occlus
ion of the reservoir in two other patients.
CONCLUSION: By use of this method, reoperation was avoided and the patients
were mobile early in the postoperative period. This method was suitable fo
r refractory chronic subdural hematoma accompanied by severe disease that a
dversely influenced the clinical course.